Published 15th April 2024
Ahead of the 31st of January 2024 marking a year until all EU clinical trials need to be compliant with the EU Clinical Trials Regulation (CTR), this whitepaper delves into different aspects we have observed that can become ‘sticking points’ for Sponsors wanting to conduct clinical trials under the CTR. Our analysis has highlighted six key topics, encompassing our experience of the overall clinical trial application (CTA) assessment process, data transparency and publication, transitioning from the Clinical Trial Directive (CTD) to the CTR, the EU CTR Systems Environment, EU Legal Representative requirements, and Article 32 paediatric requirements.
Need personalised assistance to prepare for the new regulation? Contact our experts at hello@dlrcgroup.com
Download nowPublished Dec 06, 2024
Published Dec 03, 2024
Published Dec 02, 2024
Published Nov 28, 2024
Published Nov 15, 2024
Published Nov 12, 2024
Published Oct 21, 2024
Published Oct 10, 2024
Published Oct 07, 2024